Description
CJC-1295 With DAC
Long-Acting Growth Hormone Releasing Hormone Analog
CJC-1295 With DAC is a synthetic analog of growth hormone releasing hormone (GHRH) modified with a Drug Affinity Complex (DAC) to extend its half-life through albumin binding. It is widely studied in scientific literature for its role in cellular processes related to GHRH receptor signaling and prolonged peptide interaction.
Within research environments, CJC-1295 With DAC is frequently referenced in studies exploring sustained growth hormone release patterns and extended receptor-mediated signaling. Its structure allows for targeted investigation into biological systems associated with prolonged peptide stability, somatotropic axis activity, and elevated baseline signaling cascades.
Ongoing laboratory and academic research continues to examine CJC-1295 With DAC’s broader role in GHRH pathways, receptor interaction, and biochemical activity. Its long-acting profile makes it a consistent focus in advanced peptide stability and combination research.
Research Focus Areas
- GHRH receptor signaling pathways
- Extended peptide half-life mechanisms
- Somatotropic axis interaction studies
- Combination peptide research models
Notice: This material is intended for educational and research use only by qualified professionals. It is not approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, or prevention of any disease. No clinical use guidance is provided.
